FDA tells Johnson & Johnson to toss 60M COVID-19 vaccine doses over contamination considerations: file


Get real time updates directly on you device, subscribe now.

Johnson & Johnson declined to touch upon a file that the FDA mentioned to throw out 60 million doses of its COVID-19 vaccine that was once produced at a afflicted Maryland facility over considerations of imaginable contamination. The file, printed by way of the New York Occasions, cited folks acquainted with the placement and springs because the FDA introduced it approved two batches of the vaccine produced on the Emergent BioSolutions facility in Baltimore however discovered “several other batches” now not appropriate to be used. 

The FDA additionally famous in a information free up posted Friday that “additional batches are still under review and the agency will keep the public informed as those reviews are completed.” At the moment, the company said that it’s “not yet ready to include the Emergent BioSolutions plant in the Janssen EUA as an authorized manufacturing facility,” and continues to “work through issues there with Janssen and Emergent BioSolutions management.” 


A Johnson & Johnson spokesperson declined to remark to Fox Information at the subject. 

This can be a creating tale, please proceed to test again for updates. 

Get real time updates directly on you device, subscribe now.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More